Hikma buys Baxter Healthcare's injectables business

31 October 2010

Deal worth $112m

Jordan-based Hikma Pharmaceuticals has signed a $112m agreement to acquire US-based Baxter Healthcare Corporation’s US generic injectables business. The multi source injectables business comprises a comprehensive and complementary portfolio of 41 products in over 150 dosage strengths and forms across 23 therapeutic areas.

A MEED Subscription...

Subscribe or upgrade your current MEED.com package to support your strategic planning with the MENA region’s best source of business information. Proceed to our online shop below to find out more about the features in each package.

Get Notifications